
|Articles|March 3, 2008
Post-marketing liver injury reports lead to Tysabri PI update
Liver injury warnings added to natalizumab prescribing information.
Advertisement
Reports of markedly elevated serum hepatic enzymes and elevated total bilirubin in patients receiving natalizumab (
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
TrumpRx Officially Launches, Introduces Drug Prices
2
Q&A: PBMs, Community Pharmacy’s Next Move Following PBM Reform Signing
3
President Trump Signs Sweeping, Unprecedented Federal PBM Reform
4
As Immunization Schedules Change, Vaccine Confidence Among Patients Falters
5























